Home Resources Biotech and Pharmaceutical 2020 Report - Research Report by BlueVoyant Biotech and Pharmaceutical 2020 Report – Research Report by BlueVoyant December 11, 2020 BlueVoyant Report Reveals Biotech and Pharmaceutical Industry under Aggressive and Targeted Attack. As the industry ramps up global vaccine production and distribution, the report highlights the attack types and emerging threats that are likely to intensify. Key findings include: The number one emerging threat in 2020 is nation-state espionage aimed at stealing COVID-19 vaccine research data. That said, the top threat overall is still ransomware. COVID-19 vaccines are the crown jewels in 2020 with eight of the most prominent companies in the race for a vaccine facing high volumes of targeted malicious attacks. Analysis of threat intelligence data shows that biotech and pharmaceutical companies are under massive and daily attack Of the 25 attacks reported to the media since 2017, 10 (40%) took place in 2020. Read more around the key implications that the biotech and pharmaceutical industries are facing and how to monitor and mitigate these new attack vectors during the most critical time in their existence. “2020 Biotech and Pharmaceutical Report” Share: Facebook Twitter LinkedIn Related reading Blog 3PR Risk for Prime Contractors and Mitigation Steps This post focuses on the overall protection of the defense industrial base’s supply chain security and the role of the prime contractor. Read more News BlueVoyant Honored with 5-Star Rating in the 2021 CRN® Partner Program Guide New York, N.Y., March 30, 2021 – BlueVoyant, a cybersecurity services company, is being acknowledged by CRN®, a brand of The Channel Company, in its 2021… Read more Identifying threats BlueVoyant Review: Semiconductors, the Supply Chain, and Cyber Security 2021 This report by BlueVoyant looks at semiconductors, the supply chain, and cyber security. Read more Recommended reading Identifying threats BlueVoyant Review: Semiconductors, the Supply Chain, and Cyber Security 2021 This report by BlueVoyant looks at semiconductors, the supply chain, and cyber security.
December 11, 2020 BlueVoyant Report Reveals Biotech and Pharmaceutical Industry under Aggressive and Targeted Attack. As the industry ramps up global vaccine production and distribution, the report highlights the attack types and emerging threats that are likely to intensify. Key findings include: The number one emerging threat in 2020 is nation-state espionage aimed at stealing COVID-19 vaccine research data. That said, the top threat overall is still ransomware. COVID-19 vaccines are the crown jewels in 2020 with eight of the most prominent companies in the race for a vaccine facing high volumes of targeted malicious attacks. Analysis of threat intelligence data shows that biotech and pharmaceutical companies are under massive and daily attack Of the 25 attacks reported to the media since 2017, 10 (40%) took place in 2020. Read more around the key implications that the biotech and pharmaceutical industries are facing and how to monitor and mitigate these new attack vectors during the most critical time in their existence. “2020 Biotech and Pharmaceutical Report” Share: Facebook Twitter LinkedIn Related reading Blog 3PR Risk for Prime Contractors and Mitigation Steps This post focuses on the overall protection of the defense industrial base’s supply chain security and the role of the prime contractor. Read more News BlueVoyant Honored with 5-Star Rating in the 2021 CRN® Partner Program Guide New York, N.Y., March 30, 2021 – BlueVoyant, a cybersecurity services company, is being acknowledged by CRN®, a brand of The Channel Company, in its 2021… Read more Identifying threats BlueVoyant Review: Semiconductors, the Supply Chain, and Cyber Security 2021 This report by BlueVoyant looks at semiconductors, the supply chain, and cyber security. Read more Recommended reading Identifying threats BlueVoyant Review: Semiconductors, the Supply Chain, and Cyber Security 2021 This report by BlueVoyant looks at semiconductors, the supply chain, and cyber security.
Blog 3PR Risk for Prime Contractors and Mitigation Steps This post focuses on the overall protection of the defense industrial base’s supply chain security and the role of the prime contractor. Read more
News BlueVoyant Honored with 5-Star Rating in the 2021 CRN® Partner Program Guide New York, N.Y., March 30, 2021 – BlueVoyant, a cybersecurity services company, is being acknowledged by CRN®, a brand of The Channel Company, in its 2021… Read more
Identifying threats BlueVoyant Review: Semiconductors, the Supply Chain, and Cyber Security 2021 This report by BlueVoyant looks at semiconductors, the supply chain, and cyber security. Read more
Identifying threats BlueVoyant Review: Semiconductors, the Supply Chain, and Cyber Security 2021 This report by BlueVoyant looks at semiconductors, the supply chain, and cyber security.
